APA

Mondal S. K., Jinka S., Pal K., Nelli S., Dutta S. K., Wang E., Ahmad A., AlKharfy K. M., Mukhopadhyay D. & Banerjee R. (20171020). Glucocorticoid Receptor-Targeted Liposomal Codelivery of Lipophilic Drug and Anti-Hsp90 Gene: Strategy to Induce Drug-Sensitivity, EMT-Reversal, and Reduced Malignancy in Aggressive Tumors. : Molecular pharmaceutics.

Chicago

Mondal Sujan Kumar, Jinka Sudhakar, Pal Krishnendu, Nelli Swetha, Dutta Shamit Kumar, Wang Enfeng, Ahmad Ajaz, AlKharfy Khalid M, Mukhopadhyay Debabrata and Banerjee Rajkumar. 20171020. Glucocorticoid Receptor-Targeted Liposomal Codelivery of Lipophilic Drug and Anti-Hsp90 Gene: Strategy to Induce Drug-Sensitivity, EMT-Reversal, and Reduced Malignancy in Aggressive Tumors. : Molecular pharmaceutics.

Harvard

Mondal S. K., Jinka S., Pal K., Nelli S., Dutta S. K., Wang E., Ahmad A., AlKharfy K. M., Mukhopadhyay D. and Banerjee R. (20171020). Glucocorticoid Receptor-Targeted Liposomal Codelivery of Lipophilic Drug and Anti-Hsp90 Gene: Strategy to Induce Drug-Sensitivity, EMT-Reversal, and Reduced Malignancy in Aggressive Tumors. : Molecular pharmaceutics.

MLA

Mondal Sujan Kumar, Jinka Sudhakar, Pal Krishnendu, Nelli Swetha, Dutta Shamit Kumar, Wang Enfeng, Ahmad Ajaz, AlKharfy Khalid M, Mukhopadhyay Debabrata and Banerjee Rajkumar. Glucocorticoid Receptor-Targeted Liposomal Codelivery of Lipophilic Drug and Anti-Hsp90 Gene: Strategy to Induce Drug-Sensitivity, EMT-Reversal, and Reduced Malignancy in Aggressive Tumors. : Molecular pharmaceutics. 20171020.